Victor Maximov, PhD, MBA^1*, Christopher R. Bolen, PhD^1*, Andrew G. Polson, PhD^1*, Elicia Penuel, PhD¹ and Elisabeth A. Lasater, PhD^2*

¹Genentech, Inc., South San Francisco, CA
²Genentech, South San Francisco, CA

Tibor Schomber, PhD^1*, Beatrix Stelte-Ludwig, PhD^1*, Anne-Sophie Rebstock, PhD^1*, Oliver v Ahsen, PhD^2*, Amy J Johnson, PhD³, Raquel Izumi, PhD³ and Ahmed Hamdy, MD³

¹Vincerx Pharma GmbH, Monheim, Germany
²Nuvisan ICB GmbH, Berlin, Germany
³Vincerx Pharma, Palo Alto, CA

Brendan C Bender^1*, Chi-Chung Li, PhD^1*, Mathilde Marchand, PharmD, PhD^2*, David C. Turner, PhD^1*, Feifei Li, MS^1*, Shweta Vadhavkar^1*, Bei Wang^1*, Rong Deng, PhD^1*, James Lu, PhD^1*, Jin Jin, PhD^3*, Chunze Li, PhD^3*, Shen Yin, PhD^1*, Michael C. Wei, MD, PhD¹ and Pascal Chanu, PharmD^1*

¹Genentech, Inc., South San Francisco, CA
²Certara, Inc., Marseille, France
³Genentech Inc., South San Francisco, CA

Sungho Moon^1*, Miyeon Chun^2,3*, Sangwoo Kim^1,4*, Hanna Seo^2*, Kyeong eun Kim^2,3*, Geummi Cho^2,3*, Chul Kim, MD, PhD^1*, Dok Hyun Yoon, MD, PhD^5*, Yoon Se Lee, MD, PhD^6*, Tae Min Kim, MD, PhD^7*, Eun-Jae Chung, MD, PhD^8* and Junho Chung, MD, PhD^2,3,9*

¹Progeneer Incorporation, Seoul, Korea, Republic of (South)
²Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
³Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
⁴School of Chemical Engineering, Sungkyunkwan University, Suwon, Korea, Republic of (South)
⁵Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁶Department of Otolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea, Republic of (South)
⁷Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁸Department of Otolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁹Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)

Tiange Lu^1*, Xiangxiang Zhou^2*, Zhuoya Yu^1*, Linquan Zhan^1*, Bingyu Liu, MS^3*, Mengfei Ding^1* and Xin Wang, MD, PhD¹

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
³Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan,Shandong, AL, China

Eveline Schaadt^1*, Christina Heitmüller^1*, Solveig Peters^1*, Kristina Ilieva^1*, Derek Blair^1*, Christiane Huth^1*, Dominik Bartel^1*, Sandra Zapf^1*, Markus Eberl^1*, Doris Mangelberger-Eberl^1*, Frank Giles² and Carsten Corvey^1*

¹MorphoSys AG, Planegg, Germany
²MorphoSys US Inc., Boston, MA

Paola Manara, MS¹, Alexa Barroso^1*, Abdessamad Youssfi Alaoui, PhD^2*, Tyler A Cunningham, PhD^1*, David H. Ho, PhD^3*, Kyle Hoffman^4* and Jonathan H. Schatz, MD^1,5

¹Sylvester Comprehensive Cancer Center, Miller School Medicine, University of Miami, Miami, FL
²Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Ananke Therapeutics, Cambridge, MA
⁴Bioinformatics Solutions Inc, Waterloo, ON, Canada
⁵Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL

Matthew Bernstein, PhD^1*, Elizabeth Scanlon^1*, Alexandria Fusco^1*, Frano Irvine^1*, Flavian D Brown, PhD^2*, Jeffrey D Colbert, PhD^3*, Matthew A Huggins, PhD^1*, Michael Ross, PhD^1*, Ming Tang, PhD^1* and Shruti Malu, PhD^1*

¹Immunitas Therapeutics, Waltham, MA
²GV20 Therapeutics, Cambridge, MA
³Normunity, Connecticut

Yusuke Tashiro^1*, Kotaro Shirakawa, MD, PhD¹, Ryosuke Nomura, MD^1*, Yoshihito Horisawa^1*, Stanford Emani^1*, Suguru Takeuchi, MD^1*, Jelagat Caroline^1*, Yasuhiro Kazuma, MD, PhD^1*, Kosuke Yusa, PhD^2* and Akifumi Takaori-Kondo, MD, PhD¹

¹Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
²Laboratory of Stem Cell Genetics, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan

Vicki Plaks, PhD^1*, Vidusha Cyril, MS^1*, Peter A Riedell, MD², Qianqian Zhao, PhD^1*, Jason Hall, PhD^1*, Joel Tan, PhD^1*, Diala Harb, PhD^3* and Matthew S. Davids, MD, MMSc⁴

¹AbbVie, North Chicago, IL
²David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
³Abbvie, North Chicago, IL
⁴Dana-Farber Cancer Institute, Boston, MA

Kadriye Nehir Cosgun, PhD^1*, Mark E Robinson, PhD^1*, Salim Oulghazi, MD^1*, Liang Xu, PhD^2*, Gang Xiao, PhD^3*, Lai N Chan, PhD¹, Jaewoong Lee, PhD^1,4*, Kohei Kume, PhD^1*, Etienne Leveille, MD-PhD^1*, David Fonseca Arce^1*, Dhruv Khanduja^1*, Niklas Feldhahn, PhD^5*, Joo Y. Song, MD⁶, Wing C. Chan, MD⁶, Jianjun Chen, PhD⁷, M. Mark Taketo, PhD^8*, Hilde Schjerven, PhD^9*, Julia Jellusova, PhD^10*, Shalin Kothari, MD^1*, Matthew S. Davids, MD, MMSc¹¹ and Markus Müschen, MD¹

¹Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
²College of Life Sciences, Zhejiang University, Hangzhou, China
³School of Medicine, Zhejiang University, Hangzhou, China
⁴School of Biosystems and Biomedical Sciences, Korea University, Seoul, Korea, Republic of (South)
⁵Immunology&Inflammation, Centre for Haematology, Imperial College London, London, ENG, United Kingdom
⁶Beckman Research Institute, City of Hope, Duarte, CA
⁷Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA
⁸Kyoto University, Kyoto, Japan
⁹Department of Laboratory Medicine, UCSF, San Francisco, CA
¹⁰Center for Translational Cancer Research, Technical University Munich, Munich, Germany
¹¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Sean R Corcoran, PhD^1,2,3*, Jaewoo Choi, PhD⁴, Rachel E Fenner^1*, Xin Yu^4*, Sebastian Scheich, MD^5*, Tony Hsiao^6*, Galina Schevchenko, PhD^1*, Vivian M Morris^7*, James D Phelan, PhD^4*, Evangelia K Papachristou^8*, Kamal Kishore, PhD^8*, Clive S D'Santos, PhD^9*, Yanlong Ji, PhD^10*, Stefania Pittaluga, MD, PhD^11*, George Wright^12*, Henning Urlaub^13*, Kuan-Ting Pan^14*, Thomas Oellerich, Prof. MD^15*, Jagan R. Muppidi, MD, PhD^4*, Daniel James Hodson, MD-PhD¹⁶ and Louis M. Staudt, MD, PhD⁴

¹Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
²Boston University Chobanian and Avedisian School of Medicine, Boston, MA
³Lymphoid Malignancies Branch, NIH/NCI, Boston, MA
⁴Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Goethe University, Frankfurt Am Main, DEU
⁶NIH/NCI, Bethesda
⁷Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
⁸Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
⁹University of Cambridge, Cambridge, GBR
¹⁰Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany
¹¹Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD
¹²Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹³Max-planck-Institut Für Biophysikalische Chemie, Göttingen, DEU
¹⁴MPI For Biophysical Chemistry, Goettingen, DEU
¹⁵Goethe University, Frankfurt, DEU
¹⁶Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, GBR

David Granger, PhD^1*, Vincent Muczynski, PhD^1,2*, Patricia Henne, PhD^1*, Annalisa Baccaro^1*, Dinusha Fernando^1*, Mittal Shah, PhD^3*, John Devlin, PhD^1*, Kieran O'Donovan, PhD^1* and Amit C. Nathwani, MD, PhD^1,4,5

¹NovalGen Ltd, London, United Kingdom
²Cancer Institute, University College London, London, United Kingdom
³NovalGen Ltd, London, ENG, United Kingdom
⁴Royal Free London - NHS Foundation Trust, London, United Kingdom
⁵Cancer Institute, UCL, London, ENG, United Kingdom

William Lee^1*, Vivian Changying Jiang, PhD², Tianci Zhang, MS^2*, Fangfang Yan, PhD^2*, Qingsong Cai, PhD^1*, Joseph McIntosh, BS^2*, Yang Liu, PhD^1* and Michael L. Wang, MD¹

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Yu Bai^1*, Ting Wu^1*, Minghui Hu^1*, Sufang Han^1*, Yu Liu^1*, Jie Zheng^1*, Junjun Qin^1*, Lin Zhang^1* and Zhenfan Yang, PhD²

¹Dizal Pharmaceutical, Shanghai, China
²Dizal Pharmaceutical, China, Shanghai, China

Xiaoxuan Wang^1*, Yidan Zhang^1*, Xianyou Xia^2*, Yixin Yao, PhD³, Xudong Wu^2*, Xianhuo Wang^1* and Huilai Zhang, MD^1*

¹Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Tianjin Medical University, TIANJIN, China
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Maarten Derks^1*, Marian C. Bryan^2*, Cindy Rockx^1*, Tamara Schults^1*, Tinne Verhulst^1*, Beth Pietrak^2*, Tatsuya Maehigashi, PhD^2*, James C. Robertson^3*, Andrew H. DeMaria^3*, Kimberly Holt, PhD^2*, Shaofei Ji^3*, Victoria Wong, PhD^2*, Ruud Bueters^1*, Seong Joo Koo, PhD^1*, Stefan Masure^1*, Balpreet Bhogal, PhD^4*, Christopher B. Kelly^3*, Kaushik Mitra^3*, Leopoldo Luistro, PhD^4*, Paul L. Shaffer^3*, Lawrence Szewczuk, PhD^2*, Yusri Elsayed, MD, MMSc, PhD⁴ and Ulrike Philippar, PhD¹

¹Janssen Research & Development, LLC, Beerse, Belgium
²Janssen Research & Development, LLC, Spring House
³Janssen Research & Development, LLC, Springhouse
⁴Janssen Research & Development, LLC, Spring House, PA

Adam Yuh Lin, MD, PhD¹, Eva Yang^2*, Jonathan S Rink, PhD^3*, Dan Xu, PhD^4*, Stephen Miller, PhD^4* and Leo I. Gordon, MD⁵

¹Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
²Northwestern University Feinberg School of Medicine, Chicago, IL
³Department of Medicine, Division of Hematology/ Oncology, Feinberg School of Medicine, Northwestern University, Park Ridge, IL
⁴Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL
⁵Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

Dingyao Hu^1*, Jiaowu Cao^1*, Dedao Wang^1*, Jiajin Wu^1*, Lan Mi^1*, Lingyan Ping^1*, Ning Ding^1*, Yuqin Song¹ and Jun Zhu, PhD²

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China
²Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China